WHO

 {Photo credit: Rachel Hassinger/MSH}L to R: Dr. Jonathan D. Quick, Stefanie Friedhoff, Dr. Peter PiotPhoto credit: Rachel Hassinger/MSH

On March 27, 2015, Dr. Peter Piot of the London School of Tropical Medicine and Hygiene and Dr. Jonathan D. Quick, MSH President and CEO, sat down at the Boston Public Library with Stefanie Friedhoff of The Boston Globe to discuss Ebola, epidemic preparedness and rebuilding public health systems. 

Watch the video of the whole program:

Here are some excerpts from their conversation:

Stefanie Friedhoff: What did countries do that worked well in the Ebola fight?

Jonathan Quick: There were 6 things that worked well in three of the rim countries of Nigeria, Mali and Senegal.

  1. Leadership: Ministers of Health were on top of the first cases and declared national emergencies.
  2. Preparedness of public health systems.
  3. Rapid action in getting the index case identified and case detection system for subsequent cases.
  4. Good communications campaigns.
  5. Mobilizing the community.
  6. Heroism of local health workers.

SF: Why was the international response so slow? What should be done?

 {Photo credit: MSH/#ToastUHC photo booth/RH}Yvonne Chaka Chaka (center) with members of the UN Mission from Japan (including Toshihisa Nakamura and Masaki Inasa), and Sumie Ishii of JOICFP.Photo credit: MSH/#ToastUHC photo booth/RH

Experience "A Toast to Universal Health Coverage" () through photos and tweets in this Storify story . (Storify is a social media tool for curating digital content, such as photos, videos, links, and tweets.) You can also view the complete Photo album: " Photo Booth" on Facebook. (Share and tag these photos via Facebook, Twitter, Instagram, or your favorite social media channel, using hashtag .)

 {Photo credit: MSH}H.E. Dr. Suraya Dalil, Minister of Public Health, AfghanistanPhoto credit: MSH

This post, cross-posted with permission from The Leadership, Managment, and Governance (LMG) project blog on LMGforHealth.org, is part of our Global Health Impact series on the 67th World Health Assembly in Geneva, May 18-24, 2014. MSH is co-hosting three side events focusing on the role of universal health coverage (May 20), chronic diseases (May 20), and governance for health (May 21) in the post-2015 framework. This year, six MSH representatives are attending WHA as part of the 60-plus-person Global Health Council (GHC) delegation.

 {Photo courtesy of Erik Törner/Individuell Människohjälp.}Health clinic in Kathmandu, Nepal.Photo courtesy of Erik Törner/Individuell Människohjälp.

Cross-posted with permission from The Wilson Center’s NewSecurityBeat.org.

The global maternal health agenda has been largely defined by the Millennium Development Goals (MDGs) for the last decade and half, but what will happen after they expire in 2015? What kind of framework is needed to continue the momentum towards eliminating preventable maternal deaths and morbidities? [Video Below]

For a panel of experts gathered at the Wilson Center on February 20, universal health coverage is a powerful mechanism that may be crucial to finishing the job.

{Photo credit: Reavis/MSH, Malawi}Photo credit: Reavis/MSH, Malawi

The World Health Organization (WHO) made waves at the International AIDS Society conference in Kuala Lumpur when it issued revised guidelines for HIV treatment. The new guidelines—WHO’s first major update since 2010—recommend an earlier start to treatment, from a CD4 threshold of 350 cells/mm3 to 500 cells/mm3. While most patients don’t show symptoms of disease at these higher CD4 counts (a measure of immune system strength), the new guidelines responded to evidence that an earlier start improves long-term clinical outcomes and that ARV treatment dramatically reduces patients’ likelihood of transmitting the virus to sexual partners.

{Photo credit: Warren Zelman}Photo credit: Warren Zelman

Originally posted on Devex.

“If you want to go fast, go alone,” says an African proverb. “If you want to go far, go together.”

It’s been thirteen years since the international community adopted the Millennium Development Goals, an ambitious, self-imposed “report card” for global development that helped focus attention and resources on issues like HIV and AIDS. Since then, the global HIV response has gone fast. In 2002, just 300,000 people with HIV were receiving antiretroviral therapy in developing countries; today, UNAIDS reports, treatment reaches nearly 10 million.

World Hepatitis Day is commemorated July 28. {Photo credit: C. Urdaneta/MSH, Afghanistan.}Photo credit: C. Urdaneta/MSH, Afghanistan.

Hepatitis is a personal disease for me.  Some years ago, I spent two weeks leading training workshops for faculty at the University of Costa Rica in San Jose, Costa Rica. The work and the participants were delightful, as we worked together to improve medicine prescribing practices. Every day I ate lunch at a local seafood restaurant, often joined by a colleague. One Friday, two weeks after returning home, I felt exhausted—so tired that I could not continue working. By Sunday I was orange as a pumpkin, unable to walk or keep food down. I visited my physician and was diagnosed with acute, severe hepatitis A. I felt like I was dying. I lost 6 weeks of work and 25 pounds before I was able to return to normal functioning. I discovered that the colleague who had joined me for lunch developed hepatitis A with the same intensity and duration, and at the same time.  We traced this “point source outbreak” to some uncooked mussels that the restaurant used in a fish sauce that transmitted the hepatitis A virus to us both.

World Malaria Day 2013 {Photo credit: UNHCR/S. Hoibak.}Photo credit: UNHCR/S. Hoibak.

To me, malaria is a very personal disease.

I first came face to face with malaria during the war of my time: Vietnam. I was plucked out of residency after my first year, with only an internship under my belt, and sent as a Navy Medical Officer to war. Medical school and residency prepared me well for much of the trauma I encountered medically, but I was totally unprepared for the large-scale emotional trauma, and for the tropical diseases I had encountered only in books.

I was overwhelmed by the young children with malaria, some of whom literally died in my arms while treating them.  Yet, I also witnessed bona fide miracles: children at death’s door, comatose and unresponsive, who responded dramatically to treatments, and ultimately went home to their families.

To address malaria, I focused on promoting prevention (long-lasting insecticidal nets [LLINS] for families and intermittent preventive treatment [IPT] for pregnant women), early detection, and early treatment in the community—what is now called community case management.

That was 40 years ago.

We know what works to save the lives of children under five years old: We know which antibiotic to give for treating pneumonia, for example. Yet only 31% of children with suspected pneumonia receive antibiotics. And two million children die from pneumonia and diarrhea each year.

This week’s Lancet returns the spotlight to Option B+, an innovative strategy for preventing mother-to-child transmission of HIV which was first developed in Malawi with technical assistance from MSH. Four letters respond to the concern that international organizations have too quickly endorsed the Option B+ approach of providing lifelong triple antiretroviral therapy (ART), irrespective of CD4 count, to pregnant women with HIV in high-burden countries.

MSH experts Scott Kellerman, Jonathan Jay and Jonathan Quick argue that “a strong case exists for expanding research on Option B+, but not for impeding countries that pursue it on the basis of available evidence and programmatic experience:”

Pages

Printer Friendly Version
Subscribe to RSS - WHO